Worth Venture Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Worth Venture Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-77,696	Closed	-$775K	–	222
2022 Q4	$775K	Sell	77,696 -48,839	-39%	-$364K	0.46%	58
2022 Q3	$697K	Buy	126,535 +2,135	+2%	+$11.8K	0.43%	63
2022 Q2	$631K	Buy	+124,400	New	+$588K	0.37%	71
2019 Q2	–	Sell	-56,446	Closed	-$212K	–	117
2019 Q1	$212K	Sell	56,446 -50,554	-47%	-$177K	0.12%	65
2018 Q4	$368K	Buy	107,000 +57,000	+114%	+$281K	0.28%	52
2018 Q3	$359K	Buy	+50,000	New	+$388K	0.27%	46

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Worth Venture Partners's APEN Position: Q1 2023 in Review

Worth Venture Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 77,696 shares — an estimated $775K sold.

Worth Venture Partners first reported a position in APEN in Q3 2018 and held it in 6 quarters. The position peaked at $775K in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

Worth Venture Partners reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
Worth Venture Partners sold 77,696 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $775K.
Worth Venture Partners first reported a position in Apollo Endosurgery, Inc. in Q3 2018 and held it in 6 quarters.
Worth Venture Partners's Apollo Endosurgery, Inc. position peaked at $775K in Q4 2022.
89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.